Phillip G Popovich

Author PubWeight™ 73.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009 6.93
2 Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006 5.32
3 Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2007 3.06
4 Replication and reproducibility in spinal cord injury research. Exp Neurol 2011 2.31
5 Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation 2011 2.02
6 Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 2003 1.94
7 Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem 2007 1.92
8 Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol 2006 1.84
9 Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci 2009 1.80
10 Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J Neurosci 2011 1.59
11 Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol 2007 1.52
12 An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J Neurosci Methods 2009 1.48
13 Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp Neurol 2008 1.46
14 B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest 2009 1.37
15 Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration. Prog Brain Res 2009 1.35
16 Inflammation and axon regeneration. Curr Opin Neurol 2011 1.33
17 Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci 2002 1.33
18 Characterization and modeling of monocyte-derived macrophages after spinal cord injury. J Neurochem 2007 1.28
19 Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J Neurochem 2006 1.25
20 Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J Neuroinflammation 2010 1.24
21 Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation. Brain Behav Immun 2009 1.18
22 Progranulin expression is upregulated after spinal contusion in mice. Acta Neuropathol 2009 1.17
23 Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury. J Neurosci 2005 1.16
24 Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J Neuropathol Exp Neurol 2007 1.15
25 A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma 2010 1.13
26 Stress hormones collaborate to induce lymphocyte apoptosis after high level spinal cord injury. J Neurochem 2009 1.11
27 Autonomic dysreflexia causes chronic immune suppression after spinal cord injury. J Neurosci 2013 1.07
28 Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J Neurosci 2004 1.07
29 MICAL flavoprotein monooxygenases: expression during neural development and following spinal cord injuries in the rat. Mol Cell Neurosci 2005 1.07
30 B cells and autoantibodies: complex roles in CNS injury. Trends Immunol 2010 1.05
31 Minimum information about a spinal cord injury experiment: a proposed reporting standard for spinal cord injury experiments. J Neurotrauma 2014 1.05
32 Semi-automated Sholl analysis for quantifying changes in growth and differentiation of neurons and glia. J Neurosci Methods 2010 1.05
33 A mouse model of ischemic spinal cord injury with delayed paralysis caused by aortic cross-clamping. Anesthesiology 2010 1.00
34 Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation. J Immunol 2013 1.00
35 Macrophage depletion alters the blood-nerve barrier without affecting Schwann cell function after neural injury. J Neurosci Res 2007 0.98
36 Central nervous system and non-central nervous system antigen vaccines exacerbate neuropathology caused by nerve injury. Eur J Neurosci 2007 0.98
37 Anxiety after cardiac arrest/cardiopulmonary resuscitation: exacerbated by stress and prevented by minocycline. Stroke 2009 0.97
38 Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response. J Neuroinflammation 2010 0.97
39 Achieving CNS axon regeneration by manipulating convergent neuro-immune signaling. Cell Tissue Res 2012 0.95
40 Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J Neurosci 2012 0.94
41 Toll-like receptors in spinal cord injury. Curr Top Microbiol Immunol 2009 0.93
42 Effects of gabapentin on muscle spasticity and both induced as well as spontaneous autonomic dysreflexia after complete spinal cord injury. Front Physiol 2012 0.90
43 p53 Regulates the neuronal intrinsic and extrinsic responses affecting the recovery of motor function following spinal cord injury. J Neurosci 2012 0.90
44 System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo. Exp Neurol 2011 0.90
45 Development of a database for translational spinal cord injury research. J Neurotrauma 2014 0.90
46 Debate: "is increasing neuroinflammation beneficial for neural repair?". J Neuroimmune Pharmacol 2006 0.89
47 Emerging concepts in myeloid cell biology after spinal cord injury. Neurotherapeutics 2011 0.89
48 Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Expert Opin Ther Targets 2011 0.89
49 Spinal cord injury with unilateral versus bilateral primary hemorrhage--effects of glibenclamide. Exp Neurol 2011 0.86
50 Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress. Exp Neurol 2012 0.86
51 Role of induced hypothermia in thoracoabdominal aortic aneurysm surgery. Ther Hypothermia Temp Manag 2012 0.86
52 Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice. J Neurotrauma 2014 0.85
53 Biomaterial design considerations for repairing the injured spinal cord. Crit Rev Biomed Eng 2011 0.84
54 Spinal cord injury causes chronic liver pathology in rats. J Neurotrauma 2014 0.83